Affinity Bancshares, Inc. (AFBI) announced on January 7 2026 that its Board of Directors authorized a new share repurchase program up to 304,524 shares of common stock, roughly 5 % of the company’s outstanding shares. The program follows a similar authorization issued in March 2025, underscoring the company’s ongoing commitment to returning capital to shareholders.
The repurchase program allows the company to buy back shares in the open market, through block trades, or via private transactions, with the timing and price chosen at management’s discretion. The program is structured to comply with SEC Rule 10b‑18 and Rule 10b5‑1, and can be suspended, terminated, or modified at any time based on market conditions or alternative investment opportunities.
Management’s decision signals confidence that the stock is undervalued and that the company has excess cash. Affinity’s recent financials show a net margin of 23.51 % and a price‑to‑book ratio near 0.99, indicating a valuation close to book value. The buyback is part of a broader capital‑allocation strategy that balances shareholder returns with liquidity for future growth initiatives.
The announcement follows the March 2025 program that authorized up to 320,480 shares, demonstrating a continued emphasis on capital returns. The new program also provides a mechanism to support the share price if market conditions warrant, while preserving flexibility for strategic investments.
The decision reflects Affinity’s strong profitability and cash‑flow generation, enabling the company to pursue capital returns without compromising its growth initiatives. Over the long term, the buyback program is expected to enhance shareholder value by reducing the share count and signaling management’s confidence in the company’s intrinsic value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.